CVE-2023-31923
Last modified
CVE-2023-31923 is a high-severity vulnerability rated 8.8/10 on the CVSS scale. Suprema BioStar 2 before 2022 Q4, v2.9.1 has Insecure Permissions. A vulnerability in the web application allows an authenticated attacker with "User Operator" privileges to create a highly privileged user account. EPSS estimates a 0.86% chance of exploitation in the next 30 days.
Description
Suprema BioStar 2 before 2022 Q4, v2.9.1 has Insecure Permissions. A vulnerability in the web application allows an authenticated attacker with "User Operator" privileges to create a highly privileged user account. The vulnerability is caused by missing server-side validation, which can be exploited to gain full administrator privileges on the system.
Metrics
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
Weakness Enumeration
Affected Software
| Vendor | Product | Versions |
|---|---|---|
| Supremainc | Biostar 2 | < 2.9.1 |
References
- https://nobugescapes.com/blog/creating-a-new-user-with-admin-privilege/Exploit, Third Party Advisory
- https://nobugescapes.com/blog/creating-a-new-user-with-admin-privilege/Exploit, Third Party Advisory
Timeline
- Published
- Last Modified
- Status
- Modified
Frequently Asked Questions
What is CVE-2023-31923?
How severe is CVE-2023-31923?
How do I fix CVE-2023-31923?
Are you affected by CVE-2023-31923?
Run a free Strix scan to check your systems for this vulnerability.
Scan your code nowSource: NVD / NIST